<description>&lt;article class= "text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "request-WEB:cee59b98-0957-4b41-b5d5-47fb322bf09a-2" data-testid= "conversation-turn-6" data-scroll-anchor="true" data-turn= "assistant"&gt; &lt;div class= "text-base my-auto mx-auto pb-10 [--thread-content-margin:--spacing(4)] thread-sm:[--thread-content-margin:--spacing(6)] thread-lg:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)"&gt; &lt;div class= "[--thread-content-max-width:40rem] thread-lg:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn" tabindex="-1"&gt; &lt;div&gt; &lt;div dir="auto" data-message-author-role="assistant" data-message-id="90a9432e-91f1-464d-b56e-d6ecea3a4bfc" data-message-model-slug="gpt-5-1"&gt; &lt;div&gt; &lt;div&gt; &lt;p data-start="49" data-end="473" data-is-last-node="" data-is-only-node=""&gt;Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. &lt;em data-start="404" data-end="435" data-is-last-node=""&gt;Sponsored by GE HealthCare.&lt;/em&gt;&lt;/p&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class="z-0 flex min-h-[46px] justify-start"&gt; &lt;/div&gt; &lt;div class="mt-3 w-full empty:hidden"&gt; &lt;div class="text-center"&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/article&gt; &lt;div class="pointer-events-none h-px w-px" aria-hidden="true" data-edge="true"&gt; &lt;/div&gt;</description>

Radiology Podcast | RSNA

The Radiological Society of North America

From Imaging to Impact: Transforming Neuro-Oncology Diagnostics-Sponsored by GE HealthCare

DEC 9, 202522 MIN
Radiology Podcast | RSNA

From Imaging to Impact: Transforming Neuro-Oncology Diagnostics-Sponsored by GE HealthCare

DEC 9, 202522 MIN

Description

*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "request-WEB:cee59b98-0957-4b41-b5d5-47fb322bf09a-2" data-testid= "conversation-turn-6" data-scroll-anchor="true" data-turn= "assistant">

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.